Re:Pfizer Covid vaccine approved for use next week in UK
by jMyles on Wednesday December 02, 2020 @10:54AM
(#25277497)
> And for COVID-19 the risks are very high.
If this is indeed the point of contention - balancing the risk of adverse outcomes from a rushed vaccine vs those from a virus, I think it's inaccurate to say that the risks from this virus, understood generally across the population, are "very high". The likelihood of contracting it is of course very high, but the risk of adverse effects are only high for a relatively small stratum of the population.
It makes sense to reserve "very high" for pathogens like HIV or Ebola, not SARS-CoV-2. For a very large majority of the population, SARS-CoV-2 has approximately equal risk to the four seasonally circulating coronaviruses, so even a small risk from an overlooked data point might be significant.
We need to reach herd immunity one way or another, so I'm not sure the discussion of individual risk is the right one. With no data being available for patients to examine ourselves, it's hard to even know how to make these decisions.
If this is indeed the point of contention - balancing the risk of adverse outcomes from a rushed vaccine vs those from a virus, I think it's inaccurate to say that the risks from this virus, understood generally across the population, are "very high". The likelihood of contracting it is of course very high, but the risk of adverse effects are only high for a relatively small stratum of the population.
It makes sense to reserve "very high" for pathogens like HIV or Ebola, not SARS-CoV-2. For a very large majority of the population, SARS-CoV-2 has approximately equal risk to the four seasonally circulating coronaviruses, so even a small risk from an overlooked data point might be significant.
We need to reach herd immunity one way or another, so I'm not sure the discussion of individual risk is the right one. With no data being available for patients to examine ourselves, it's hard to even know how to make these decisions.